TRK-700 An Early Phase II Study in Patients With Post-Herpetic Neuralgia —Double Blind Comparison With Placebo—
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 12 May 2017
At a glance
- Drugs TRK 700 (Primary)
- Indications Postherpetic neuralgia
- Focus Therapeutic Use
- Sponsors Toray Industries
- 08 May 2017 Status changed from recruiting to active, no longer recruiting.
- 17 Mar 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 15 Mar 2016 New trial record